Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, R&D

EVP, CFO and Treasurer

President and COO

EVP, CCO and CBO

EVP, Chief Strategy Officer

President and CEO

EVP, Chief Legal Officer

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CFO and Treasurer
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	President and COO
2024-03-10	Premium	acquired	Premium	Premium	Premium	President, R&D
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, CFO and Treasurer
2024-03-10	Premium	acquired	Premium	Premium	Premium	President and COO
2024-03-07	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CFO and Treasurer
2024-03-07	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2024-03-07	Premium	acquired	Premium	Premium	Premium	President, R&D
2024-03-07	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CCO and CBO
2024-03-07	Premium	acquired	Premium	Premium	Premium	EVP, CCO and CBO
2024-03-07	Premium	acquired	Premium	Premium	Premium	EVP, CFO and Treasurer
2024-03-01	Premium	acquired	Premium	Premium	Premium	EVP, Chief Strategy Officer
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Strategy Officer
2024-01-23	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-01-23	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2023-12-14	Premium	acquired	Premium	Premium	Premium	President, R&D
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Legal Officer
2023-12-14	Premium	acquired	Premium	Premium	Premium	EVP, Chief Legal Officer
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CCO and CBO
2023-12-14	Premium	acquired	Premium	Premium	Premium	EVP, CCO and CBO
2023-11-05	Premium	acquired	Premium	Premium	Premium	President, R&D
2023-11-05	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2023-10-29	Premium	acquired	Premium	Premium	Premium	-

NVAX - Novavax Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for NVAX